“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

TNF-α inhibitors in systemic vasculitides and connective tissue diseases

The introduction of TNF-α inhibitors in the treatment of rheumatoid arthritis and several other diseases meant a major progress in the management and to the understanding of these chronic inflammatory diseases. In this article, the evidence of the role of TNF-α and for TNF-α inhibitors in systemic vasculitides and connective tissue diseases is reviewed. TNF-α is expressed in inflammatory lesions. TNF-α acts as a proinflammatory cytokine in most disease processes analyzed so far, but it might have anti-inflammatory properties under certain conditions as well, e.g. with respect to B-cell regulation in systemic lupus erythematosus. It is not clear to what extent such aspects will be important in the treatment of connective tissue diseases and systemic vasculitides with TNF-α inhibitors. So far, most case reports and case series have suggested favourable results with TNF-α inhibitor therapy in systemic lupus erythematosus, dermato- and polymyositis, giant cell arteritis, Churg–Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis. Results of randomized, placebo-controlled trials are awaited for several connective tissue diseases and systemic vasculitides. One randomized, placebo-controlled trial has found no efficacy of infliximab treatment in primary Sjögren's syndrome recently. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Autoimmunity Reviews Elsevier
Loading next page...
1
 
/lp/elsevier/tnf-inhibitors-in-systemic-vasculitides-and-connective-tissue-diseases-6jt7ISxKEc

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.